Advisory - One lot of Traditional Medicinals "Throat Coat Lemon Echinacea" herbal tea recalled because of potential contamination with Salmonella
OTTAWA, April 24, 2018 /CNW/ -
Issue Health Canada is advising Canadians that one lot of "Throat Coat Lemon Echinacea" herbal tea is being voluntarily recalled by Traditional Medicinals after a company supplier found Salmonella contamination in a tea ingredient (lemon myrtle leaf). An infection caused by Salmonella bacteria may pose serious health risks, particularly for young children, pregnant women, the elderly and people with weak immune systems.
The recalled product was sold at stores across Canada and online, including Amazon Canada, Bulk Barn, Loblaws, London Drugs and Walmart. It is promoted to relieve the symptoms and shorten the duration of upper respiratory tract infections.
Who is affected
Consumers who have bought or used the affected product
Affected product
Traditional Medicinals Throat Coat Lemon Echinacea herbal tea (NPN 80028539) Lot #019, Expiry date February 2021
What consumers should do
Do not use this product. Consult with your health care professional if you have used this product and have health concerns.
Traditional Medicinals is advising consumers to discard products from the affected lot and to contact the company by telephone at 1-800-543-4372 for reimbursement or with any questions about this recall.
Report adverse events to health products to Health Canada by calling toll-free at 1?866?234?2345, or by reporting online, by mail or by fax.
Report complaints about health products to Health Canada by calling toll-free at 1?800?267?9675, or complete an online complaint form.
What Health Canada is doing Health Canada is monitoring the company's recall and will inform Canadians if new safety information arises, as needed.
Background Salmonella are bacteria that can cause intestinal illness (salmonellosis). They pose serious health risks. Symptoms of Salmonella infection include diarrhea, fever, nausea, abdominal cramps and vomiting. The symptoms can appear 12 to 72 hours after exposure and the illness usually lasts four to seven days. The risk of serious health effects is greatest for young children, pregnant women, the elderly and people with weak immune systems.
Stay connected with Health Canada and receive the latest advisories and product recalls.
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...